-
1
-
-
41349099104
-
Cancer statistics, 2008
-
DOI 10.3322/CA.2007.0010
-
A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and T. Murray Cancer statistics, 2008 CA Cancer J Clin 58 2008 71 96 (Pubitemid 351521864)
-
(2008)
CA Cancer Journal for Clinicians
, vol.58
, Issue.2
, pp. 71-96
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Murray, T.6
Thun, M.J.7
-
2
-
-
36849051967
-
Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer
-
J.R. Chien, G. Aletti, D.A. Bell, G.L. Keeney, V. Shridhar, and L.C. Hartmann Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer J Cell Biochem 102 2007 117 129
-
(2007)
J Cell Biochem
, vol.102
, pp. 117-129
-
-
Chien, J.R.1
Aletti, G.2
Bell, D.A.3
Keeney, G.L.4
Shridhar, V.5
Hartmann, L.C.6
-
3
-
-
34249947772
-
Current management strategies for ovarian cancer
-
G.D. Aletti, M.M. Gallenberg, W.A. Cliby, A. Jatoi, and L.C. Hartmann Current management strategies for ovarian cancer Mayo Clin Proc 82 2007 751 770 (Pubitemid 46878099)
-
(2007)
Mayo Clinic Proceedings
, vol.82
, Issue.6
, pp. 751-770
-
-
Aletti, G.D.1
Gallenberg, M.M.2
Cliby, W.A.3
Jatoi, A.4
Hartmann, L.C.5
-
4
-
-
33645766204
-
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin
-
S.L. Bowker, S.R. Majumdar, P. Veugelers, and J.A. Johnson Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diab Care 29 2006 254 258 (Pubitemid 44106500)
-
(2006)
Diabetes Care
, vol.29
, Issue.2
, pp. 254-258
-
-
Bowker, S.L.1
Majumdar, S.R.2
Veugelers, P.3
Johnson, J.A.4
-
5
-
-
20444461067
-
Metformin and reduced risk of cancer in diabetic patients
-
DOI 10.1136/bmj.38415.708634.F7
-
J.M. Evans, L.A. Donnelly, A.M. Emslie-Smith, D.R. Alessi, and A.D. Morris Metformin and reduced risk of cancer in diabetic patients BMJ 330 2005 1304 1305 (Pubitemid 40813563)
-
(2005)
British Medical Journal
, vol.330
, Issue.7503
, pp. 1304-1305
-
-
Evans, J.M.M.1
Donnelly, L.A.2
Emslie-Smith, A.M.3
Alessi, D.R.4
Morris, A.D.5
-
6
-
-
69549097703
-
New users of metformin are at low risk of incident cancer: A cohort study among people with type 2 diabetes
-
G. Libby, L.A. Donnelly, P.T. Donnan, D.R. Alessi, A.D. Morris, and J.M. Evans New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes Diab Care 32 2009 1620 1625
-
(2009)
Diab Care
, vol.32
, pp. 1620-1625
-
-
Libby, G.1
Donnelly, L.A.2
Donnan, P.T.3
Alessi, D.R.4
Morris, A.D.5
Evans, J.M.6
-
7
-
-
67749144226
-
Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer
-
S. Jiralerspong, S.L. Palla, S.H. Giordano, F. Meric-Bernstam, C. Liedtke, and C.M. Barnett Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer J Clin Oncol 27 2009 3297 3302
-
(2009)
J Clin Oncol
, vol.27
, pp. 3297-3302
-
-
Jiralerspong, S.1
Palla, S.L.2
Giordano, S.H.3
Meric-Bernstam, F.4
Liedtke, C.5
Barnett, C.M.6
-
8
-
-
28844433635
-
Medicine: The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
-
DOI 10.1126/science.1120781
-
R.J. Shaw, K.A. Lamia, D. Vasquez, S.H. Koo, N. Bardeesy, and R.A. Depinho The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin Science 310 2005 1642 1646 (Pubitemid 41780780)
-
(2005)
Science
, vol.310
, Issue.5754
, pp. 1642-1646
-
-
Shaw, R.J.1
Lamia, K.A.2
Vasquez, D.3
Koo, S.-H.4
Bardeesy, N.5
DePinho, R.A.6
Montminy, M.7
Cantley, L.C.8
-
9
-
-
0034773404
-
Role of AMP-activated protein kinase in mechanism of metformin action
-
DOI 10.1172/JCI200113505
-
G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, and J. Fenyk-Melody Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 108 2001 1167 1174 (Pubitemid 32995375)
-
(2001)
Journal of Clinical Investigation
, vol.108
, Issue.8
, pp. 1167-1174
-
-
Zhou, G.1
Myers, R.2
Li, Y.3
Chen, Y.4
Shen, X.5
Fenyk-Melody, J.6
Wu, M.7
Ventre, J.8
Doebber, T.9
Fujii, N.10
Musi, N.11
Hirshman, M.F.12
Goodyear, L.J.13
Moller, D.E.14
-
10
-
-
46249121405
-
Cancer therapy: Staying current with AMPK
-
D.A. Fruman, and A.L. Edinger Cancer therapy: staying current with AMPK Biochem J 412 2008 e3 e5
-
(2008)
Biochem J
, vol.412
-
-
Fruman, D.A.1
Edinger, A.L.2
-
11
-
-
44649104448
-
Targeting AMPK: A new therapeutic opportunity in breast cancer
-
S.M. Hadad, S. Fleming, and A.M. Thompson Targeting AMPK: a new therapeutic opportunity in breast cancer Crit Rev Oncol Hematol 67 2008 1 7
-
(2008)
Crit Rev Oncol Hematol
, vol.67
, pp. 1-7
-
-
Hadad, S.M.1
Fleming, S.2
Thompson, A.M.3
-
12
-
-
63849104290
-
AMP-activated protein kinase and cancer
-
W. Wang, and K.L. Guan AMP-activated protein kinase and cancer Acta Physiol (Oxf) 196 2009 55 63
-
(2009)
Acta Physiol (Oxf)
, vol.196
, pp. 55-63
-
-
Wang, W.1
Guan, K.L.2
-
13
-
-
47249088612
-
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
-
W.H. Gotlieb, J. Saumet, M.C. Beauchamp, J. Gu, S. Lau, and M.N. Pollak In vitro metformin anti-neoplastic activity in epithelial ovarian cancer Gynecol Oncol 110 2008 246 250
-
(2008)
Gynecol Oncol
, vol.110
, pp. 246-250
-
-
Gotlieb, W.H.1
Saumet, J.2
Beauchamp, M.C.3
Gu, J.4
Lau, S.5
Pollak, M.N.6
-
14
-
-
62449284551
-
Bcl2 family proteins in carcinogenesis and the treatment of cancer
-
A. Frenzel, F. Grespi, W. Chmelewskij, and A. Villunger Bcl2 family proteins in carcinogenesis and the treatment of cancer Apoptosis 14 2009 584 596
-
(2009)
Apoptosis
, vol.14
, pp. 584-596
-
-
Frenzel, A.1
Grespi, F.2
Chmelewskij, W.3
Villunger, A.4
-
15
-
-
54949132875
-
Bcl-2 family proteins and cancer
-
K.W. Yip, and J.C. Reed Bcl-2 family proteins and cancer Oncogene 27 2008 6398 6406
-
(2008)
Oncogene
, vol.27
, pp. 6398-6406
-
-
Yip, K.W.1
Reed, J.C.2
-
16
-
-
0031939573
-
Bcl-2, bax, bcl-x(L), and bcl-x(S) expression in normal and neoplastic ovarian tissues
-
M. Marone, G. Scambia, S. Mozzetti, G. Ferrandina, S. Iacovella, and A. De Pasqua bcl-2, bax, bcl-XL, and bcl-XS expression in normal and neoplastic ovarian tissues Clin Cancer Res 4 1998 517 524 (Pubitemid 28122771)
-
(1998)
Clinical Cancer Research
, vol.4
, Issue.2
, pp. 517-524
-
-
Marone, M.1
Scambia, G.2
Mozzetti, S.3
Ferrandina, G.4
Iacovella, S.5
De Pasqua, A.6
Benedetti-Panici, P.7
Mancuso, S.8
-
17
-
-
0036077270
-
The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy
-
DOI 10.1046/j.1525-1438.2002.01121.x
-
I. Skirnisdottir, T. Seidal, E. Gerdin, and B. Sorbe The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy Int J Gynecol Cancer 12 2002 265 276 (Pubitemid 34787554)
-
(2002)
International Journal of Gynecological Cancer
, vol.12
, Issue.3
, pp. 265-276
-
-
Skirnisdottir, I.1
Seidal, T.2
Gerdin, E.3
Sorbe, B.4
-
18
-
-
0032835310
-
Increased bcl-2 expression is associated with primary resistance to chemotherapy in human epithelial ovarian cancer
-
DOI 10.1016/S0009-9120(99)00026-0, PII S0009912099000260
-
S.K. Kassim, H.S. Ali, M.M. Sallam, S.T. Fayed, L.S. Seada, and E. abd-Elkawy Increased bcl-2 expression is associated with primary resistance to chemotherapy in human epithelial ovarian cancer Clin Biochem 32 1999 333 338 (Pubitemid 29416723)
-
(1999)
Clinical Biochemistry
, vol.32
, Issue.5
, pp. 333-338
-
-
Kassim, S.K.1
Ali, H.S.2
Sallam, M.M.3
Fayed, S.T.4
Seada, L.S.5
Abd-Elkawy, E.6
Seada, M.A.7
Khalifa, A.8
-
19
-
-
57649096288
-
Urinary levels of Bcl-2 are elevated in ovarian cancer patients
-
N.S. Anderson, Y. Bermudez, D. Badgwell, R. Chen, S.V. Nicosia, and R.C. Bast Jr. Urinary levels of Bcl-2 are elevated in ovarian cancer patients Gynecol Oncol 112 2009 60 67
-
(2009)
Gynecol Oncol
, vol.112
, pp. 60-67
-
-
Anderson, N.S.1
Bermudez, Y.2
Badgwell, D.3
Chen, R.4
Nicosia, S.V.5
Bast Jr., R.C.6
-
21
-
-
0019750732
-
Criteria for analyzing interactions between biologically active agents
-
M.C. Berenbaum Criteria for analyzing interactions between biologically active agents Adv Cancer Res 35 1981 269 335
-
(1981)
Adv Cancer Res
, vol.35
, pp. 269-335
-
-
Berenbaum, M.C.1
-
22
-
-
34247094747
-
Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?
-
DOI 10.1200/JCO.2006.08.2933
-
J.H. Silber, P.R. Rosenbaum, D. Polsky, R.N. Ross, O. Even-Shoshan, and J.S. Schwartz Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy? J Clin Oncol 25 2007 1169 1175 (Pubitemid 46640562)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.10
, pp. 1169-1175
-
-
Silber, J.H.1
Rosenbaum, P.R.2
Polsky, D.3
Ross, R.N.4
Even-Shoshan, O.5
Schwartz, J.S.6
Armstrong, K.A.7
Randall, T.C.8
-
23
-
-
33750546483
-
Ovarian cancer: A focus on management of recurrent disease
-
DOI 10.1038/ncponc0637, PII NCPONC0637
-
T.J. Herzog, and B. Pothuri Ovarian cancer: a focus on management of recurrent disease Nat Clin Pract Oncol 3 2006 604 611 (Pubitemid 44669715)
-
(2006)
Nature Clinical Practice Oncology
, vol.3
, Issue.11
, pp. 604-611
-
-
Herzog, T.J.1
Pothuri, B.2
-
24
-
-
0015220921
-
Age-associated elevation of hypothalamic, threshold to feedback control, and its role in development, ageine, and disease
-
V.M. Dilman Age-associated elevation of hypothalamic, threshold to feedback control, and its role in development, ageine, and disease Lancet 1 1971 1211 1219
-
(1971)
Lancet
, vol.1
, pp. 1211-1219
-
-
Dilman, V.M.1
-
25
-
-
77952196038
-
Metformin attenuates ovarian cancer cell growth in an AMP- kinase dispensable manner
-
R. Rattan, S. Giri, L. Hartmann, and V. Shridhar Metformin attenuates ovarian cancer cell growth in an AMP- kinase dispensable manner J Cell Mol Med 2009
-
(2009)
J Cell Mol Med
-
-
Rattan, R.1
Giri, S.2
Hartmann, L.3
Shridhar, V.4
-
26
-
-
44849099894
-
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
-
DOI 10.1038/sj.onc.1211024, PII 1211024
-
I. Ben Sahra, K. Laurent, A. Loubat, S. Giorgetti-Peraldi, P. Colosetti, and P. Auberger The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level Oncogene 27 2008 3576 3586 (Pubitemid 351793803)
-
(2008)
Oncogene
, vol.27
, Issue.25
, pp. 3576-3586
-
-
Sahra, I.B.1
Laurent, K.2
Loubat, A.3
Giorgetti-Peraldi, S.4
Colosetti, P.5
Auberger, P.6
Tanti, J.F.7
Le Marchand-Brustel, Y.8
Bost, F.9
-
27
-
-
65349175605
-
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
-
I.N. Alimova, B. Liu, Z. Fan, S.M. Edgerton, T. Dillon, and S.E. Lind Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro Cell Cycle 8 2009 909 915
-
(2009)
Cell Cycle
, vol.8
, pp. 909-915
-
-
Alimova, I.N.1
Liu, B.2
Fan, Z.3
Edgerton, S.M.4
Dillon, T.5
Lind, S.E.6
-
28
-
-
65849256893
-
Metformin induces apoptosis of pancreatic cancer cells
-
L.W. Wang, Z.S. Li, D.W. Zou, Z.D. Jin, J. Gao, and G.M. Xu Metformin induces apoptosis of pancreatic cancer cells World J Gastroenterol 14 2008 7192 7198
-
(2008)
World J Gastroenterol
, vol.14
, pp. 7192-7198
-
-
Wang, L.W.1
Li, Z.S.2
Zou, D.W.3
Jin, Z.D.4
Gao, J.5
Xu, G.M.6
-
29
-
-
67650514082
-
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
-
B. Liu, Z. Fan, S.M. Edgerton, X.S. Deng, I.N. Alimova, and S.E. Lind Metformin induces unique biological and molecular responses in triple negative breast cancer cells Cell Cycle 8 2009 2031 2040
-
(2009)
Cell Cycle
, vol.8
, pp. 2031-2040
-
-
Liu, B.1
Fan, Z.2
Edgerton, S.M.3
Deng, X.S.4
Alimova, I.N.5
Lind, S.E.6
-
30
-
-
77950191479
-
Targeting cancer cell metabolism: The combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells
-
I. Ben Sahra, K. Laurent, S. Giuliano, F. Larbret, G. Ponzio, and P. Gounon Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells Cancer Res 70 2010 2465 2475
-
(2010)
Cancer Res
, vol.70
, pp. 2465-2475
-
-
Ben Sahra, I.1
Laurent, K.2
Giuliano, S.3
Larbret, F.4
Ponzio, G.5
Gounon, P.6
-
31
-
-
34249069215
-
Dual antiglioma action of metformin: Cell cycle arrest and mitochondria-dependent apoptosis
-
DOI 10.1007/s00018-007-7080-4
-
A. Isakovic, L. Harhaji, D. Stevanovic, Z. Markovic, M. Sumarac-Dumanovic, and V. Starcevic Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis Cell Mol Life Sci 64 2007 1290 1302 (Pubitemid 46791062)
-
(2007)
Cellular and Molecular Life Sciences
, vol.64
, Issue.10
, pp. 1290-1302
-
-
Isakovic, A.1
Harhaji, L.2
Stevanovic, D.3
Markovic, Z.4
Sumarac-Dumanovic, M.5
Starcevic, V.6
Micic, D.7
Trajkovic, V.8
-
32
-
-
70749106139
-
Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy
-
L.A. Cantrell, C. Zhou, A. Mendivil, K.M. Malloy, P.A. Gehrig, and V.L. Bae-Jump Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy Gynecol Oncol 116 2010 92 98
-
(2010)
Gynecol Oncol
, vol.116
, pp. 92-98
-
-
Cantrell, L.A.1
Zhou, C.2
Mendivil, A.3
Malloy, K.M.4
Gehrig, P.A.5
Bae-Jump, V.L.6
-
33
-
-
44949087480
-
Polymorphism in human organic cation transporters and metformin action
-
DOI 10.2217/14622416.9.4.415
-
H. Takane, E. Shikata, K. Otsubo, S. Higuchi, and I. Ieiri Polymorphism in human organic cation transporters and metformin action Pharmacogenomics 9 2008 415 422 (Pubitemid 351803926)
-
(2008)
Pharmacogenomics
, vol.9
, Issue.4
, pp. 415-422
-
-
Takane, H.1
Shikata, E.2
Otsubo, K.3
Higuchi, S.4
Ieiri, I.5
-
34
-
-
63149129655
-
Bcl-2 inhibitors: Targeting mitochondrial apoptotic pathways in cancer therapy
-
M.H. Kang, and C.P. Reynolds Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy Clin Cancer Res 15 2009 1126 1132
-
(2009)
Clin Cancer Res
, vol.15
, pp. 1126-1132
-
-
Kang, M.H.1
Reynolds, C.P.2
-
35
-
-
0032575688
-
The Bcl-2 protein family: Arbiters of cell survival
-
J.M. Adams, and S. Cory The Bcl-2 protein family: arbiters of cell survival Science 281 1998 1322 1326 (Pubitemid 28406819)
-
(1998)
Science
, vol.281
, Issue.5381
, pp. 1322-1326
-
-
Adams, J.M.1
Cory, S.2
-
36
-
-
77953527360
-
Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena
-
B. Martin-Castillo, A. Vazquez-Martin, C. Oliveras-Ferraros, and J.A. Menendez Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena Cell Cycle 9 2010 1057 1064
-
(2010)
Cell Cycle
, vol.9
, pp. 1057-1064
-
-
Martin-Castillo, B.1
Vazquez-Martin, A.2
Oliveras-Ferraros, C.3
Menendez, J.A.4
-
37
-
-
0034659785
-
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
-
DOI 10.1042/0264-6021:3480607
-
M.R. Owen, E. Doran, and A.P. Halestrap Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem J 348 Pt 3 2000 607 614 (Pubitemid 30410251)
-
(2000)
Biochemical Journal
, vol.348
, Issue.3
, pp. 607-614
-
-
Owen, M.R.1
Doran, E.2
Halestrap, A.P.3
|